Search clinical trials for: EGP-437 1.6 mA-min at 0.4 with EyeGate® II System
Total 9 results
-
Eyegate Pharmaceuticals, Inc.CompletedUveitis, AnteriorUnited States, India
-
Eyegate Pharmaceuticals, Inc.CompletedDry Eye SyndromeUnited States
-
Eyegate Pharmaceuticals, Inc.CompletedPatients Having Undergone Unilateral Cataract Extraction and Implantation of a MonofocalUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedPregnancy | Dental Caries | Rheumatic Heart DiseaseBrazil
-
Yonsei UniversityCompletedMandibular Retrognathism | Mandibular PrognathismKorea, Republic of
-
Anabio R&DThai Binh University of Medicine and PharmacyRecruitingUpper Respiratory Tract InfectionsVietnam
-
National Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel